Contact Us
100 Cummings Center, Suite 407-P, Beverly, Massachusetts 01915, USA
+1 (978) 720-8044
Contact Us
100 Cummings Center, Suite 407-P, Beverly, Massachusetts 01915, USA
+1 (978) 720-8044
At Thrive Biosciences, our leadership team comprises visionary and operating experts with decades of experience across a wide range of industries relevant to Thrive Bioscience, including instrumentation, biotechnology, pharmaceuticals, artificial intelligence, and advanced computing.
Each leader brings unique skills and a shared commitment to innovation, ensuring that Thrive Bioscience remains at the cutting edge of automated live cell imaging to enable quantitative biology.
Thrive Bioscience addresses the persistent challenges in cell culture, such as variability in cell quality, high rates of mislabeling, cross-contamination, and cell stress, which are prevalent across laboratories worldwide.
Michael Finney, Ph.D., serves as the Chair of Thrive Bioscience and has served as a Board Director since 2014, bringing a wealth of experience and leadership in biotechnology and life sciences. As the Managing Director of Finney Capital, Mike has been instrumental in guiding companies through various stages of growth and innovation.
Mike was previously the co-founder and chief scientific officer of MJ Research, a company renowned for pioneering PCR technology work. He later served as the CEO of Vaxart, where he led efforts in developing oral vaccines. Mike's extensive experience is further highlighted by his roles on the Board of Directors of several prominent organizations, including Genome Partnership, Innerscope Research, Orion Genomics, Sage Science, and Vaxart.
Mike received his Ph.D. in Biology from the Massachusetts Institute of Technology and his Bachelor's, where he developed a deep expertise that continues to drive his contributions to the advancement of biotechnology.
Brock C. Reeve has served as a Board Director at Thrive Bioscience since 2016. Brock is a highly respected biotechnology and life sciences leader and investor.
He is currently CEO and Co-founder of Eos BioInnovation, which launches and funds companies in the regenerative medicine field, leveraging discoveries from leading academic labs. He previously was the Executive Director of the Harvard Stem Cell Institute from 2006 to 2022, overseeing pioneering research to develop stem cell-based therapies. Additionally, Brock served as the CEO of IVIVA Medical, a company dedicated to creating bioengineered organs for transplantation, acquired by United Therapeutics (NASDAQ: UTHR).
Brock's extensive career includes key leadership roles, such as Managing Director and COO of Life Science Insights, an IDC company, where he guided strategic decisions in the healthcare sector. Brock has also served as the Healthcare Practice Director at Viant, where he led initiatives to transform healthcare delivery through innovative technology solutions, and as a Principal at SRI Consulting, where he provided strategic advice to organizations in the life sciences industry.
Brock received his M.Phil at Yale University and his MBA at Harvard University and combines deep scientific knowledge with solid business acumen, driving innovation and growth in every role he undertakes.
